HIPPOCRATIC CANCER RESEARCH FOUNDATION INC (EIN 472842337) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

ELENI BOUSIS

Phone

8477783828

Tax Period

2024-01-01 to 2024-12-31

HIPPOCRATIC CANCER RESEARCH FOUNDATION INC, founded in 2014, is a small nonprofit in the Medical Research sector that reported $939K in total revenue in fiscal year 2024. Revenue surged 849% from the prior year, signaling strong growth momentum. The organization ran a surplus of $314K, a strong 33% operating margin.

Mission

ACCELERATE AND INCREASE IMPACT OF SCIENTIFIC DISCOVERIES WITHIN CANCER BIOLOGY AND ONCOLOGY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,769,102

Program Service Revenue $0

Investment Income $0

Other Revenue $-829,694

TOTAL REVENUE $939,408

Expense Breakdown

Grants Paid $500,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $500,000

Other Expenses $125,234

TOTAL EXPENSES $625,234

Year-over-Year Comparison

	2024	2023	Change
Revenue	$939,408	$98,952	+8.5%
Expenses	$625,234	$775,663	-0.2%
Net Income	$314,174	$-676,711	-1.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELENI BOUSIS	PRESIDENT	1.00	Officer Director	$0	$0	$0
PETER G KARAHALIOS	TREASURER	1.00	Officer Director	$0	$0	$0
LISA PALIVOS	SECRETARY	1.00	Officer Director	$0	$0	$0
JANELL ADAMES	DIRECTOR	1.00	Director	$0	$0	$0
GEORGE BOUSIS	DIRECTOR	1.00	Director	$0	$0	$0
PAMELLA CAPITANNI	DIRECTOR	1.00	Director	$0	$0	$0
INESE ROMANOVSKA DRIEHAUS	DIRECTOR	1.00	Director	$0	$0	$0
SUSANNE FEIN	DIRECTOR	1.00	Director	$0	$0	$0
TEDDI GALANIS	DIRECTOR	1.00	Director	$0	$0	$0
ATHENA KAMPAS	DIRECTOR	1.00	Director	$0	$0	$0
DANIELLE SAMOYLOVICH	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$939,408	$625,234	$566,727	$314,174
2023	$98,952	$775,663	$252,554	$-676,711
2022	$789,762	$429,056	$909,265	$360,706
2021	$543,863	$605,667	$548,559	$-61,804
2020	$677,252	$1,015,791	$610,363	$-338,539
2019	$846,502	$772,717	$948,902	$73,785
2018	$813,395	$414,375	$875,117	$399,020

HIPPOCRATIC CANCER RESEARCH FOUNDATION INC